<section class="s_text_block o_colored_level" style="background-image: none;">
<img src="/web/image/20729-bcf60cf2/8315840737-bec83699df.jpg?access_token=ddcad8d3-b1da-46ac-a58d-23305b7b0e75" alt="" class="img img-fluid o_we_custom_image"> <br>No single organization possesses the knowledge, resources and capabilities required to bring affordable, advanced therapy medicinal products (ATMP) and breakthrough healthcare benefits to patients worldwide. <strong>Collaboration between public and private stakeholders</strong> across the ‘quadruple helix’ - academia, industry, government, patients - is a critical success factor if the promise of moving from ‘care-to-cure’ is to be realized.<br><br>
<strong>Belgium is widely recognized as having a rich and dynamic ATMP sector</strong>, possessing the key ingredients needed to become a global leader in the advanced therapy domain. The <strong>goals</strong> of this summit are to <strong>highlight the country’s unique resources and capabilities</strong>, and to <strong>showcase some of the current developments</strong> in the cell, gene and tissue-engineered therapy domains, as well as with key enabling technologies and manufacturing infrastructure. The <strong>major challenges</strong> faced by developers of advanced therapies will be highlighted, drawing on experience of other ATMP hubs in Europe as to <strong>how gaps may be addressed </strong>in the Belgian ecosystem, sometimes cited as being too fragmented to fully realize the country’s potential.<br><br>With speakers from within Belgium and across Europe, <strong>the summit will bring together an audience of over 250 public and private stakeholders</strong> – medicine and academia, industry, government and regulators, as well as patient representatives - in what is expected to be a major event in the 2023 calendar.<br><br><a class="btn btn-primary" href="https://advancedtherapiessummit2023.b2match.io/">Info &amp; registration</a><br><p><br></p></section>